+ T cells, ILC2 and ILC3 in COPD subjects. METHODS: We included 11 mild to moderate COPD subjects (FEV 1 / FVC<70%, predicted FEV 1 > _50% and smoking history>10 pack years) who were stable 4 weeks prior to the study and were not using inhaled or oral corticosteroid therapy at time of sampling. Blood and sputum extracted cells were subject to immunofluorescence staining for flow cytometric acquisition and analyses. All data were analyzed using nonparametric methods. Amount of studies have conformed that autophagy level increased in asthmatic patients and OVA-induced asthma model. However, the role of autophagy in cockroach(CRE)-induced asthma is unclear. We have discovered that CRE-increased ROS generation and oxCaMKII promoted asthma. We hypothesize that ROS and oxCaMKII could mediate autophagy in CRE-induced allergic inflammation. METHODS: CRE-induced asthma model was built in WT mice (with or without autophagy inhibitor, 3-MA) or ROS-resistant MMVVd mice. Lung inflammation, ROS and autophagy level were assessed. Autophagy, oxCaMKII and ROS level were measured in CRE-and CRE/KN-93(CaMKII inhibitor) treated HBE cells. RESULTS: Autophagy level increased in CRE-induced mouse model of asthma. Inhibiting autophagy with 3-MA attenuated CRE-induced inflammatory cells recruitment and mucus secretion, CRE-specific IgG1 and IgE, and Th2 cytokines (IL4, IL-5 and IL13). We also discovered that CRE could induce autophagy in HBE cells through ROS dependent way. Furthermore, CRE could induce oxCaMKII expression in HBE cells, and KN-93 could attenuate CRE-induced autophagy in a dose-dependent way and decrease CRE-indcued ROS generation in vivo. Meanwhile, CREtreated ROS-resistant MMVVd mice showed less inflammation and lower level of autophagy compared to WT mice. CONCLUSIONS: Collectively, our studies implicated ROS-oxCaMKII loop played an essential role for autophagy in CRE-induced asthma, which may be a therapeutic target for allergic inflammation and asthma.
